SEC Form 4 · accession 0001424422-15-000014
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Morlock
Director
Period of report
Oct 9, 2015
Accepted (ET)
Oct 13, 2015 · 12:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Oct 9, 2015 | P | 1,000 | $1.26 | A | 221,071 | D | |
| Common stock | Oct 9, 2015 | P | 2,000 | $1.19 | A | 223,071 | D |
Table II — derivative securities
No Table II lines on this filing.